UBS O'Connor’s PRA Health Sciences, Inc. PRAH Stock Holding History

UBS O'Connor’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,781,846	Closed	-$294M	–	1076
2021 Q2	$294M	Buy	1,781,846 +1,531,846	+613%	+$256M	2.63%	12
2021 Q1	$38.3M	Buy	+250,000	New	+$34M	0.55%	20

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

UBS O'Connor's PRAH Position: Q3 2021 in Review

UBS O'Connor sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 1,781,846 shares — an estimated $294M sold.

UBS O'Connor first reported a position in PRAH in Q1 2021 and held it in 2 quarters. The position peaked at $294M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

UBS O'Connor reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
UBS O'Connor sold 1,781,846 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $294M.
UBS O'Connor first reported a position in PRA Health Sciences, Inc. in Q1 2021 and held it in 2 quarters.
UBS O'Connor's PRA Health Sciences, Inc. position peaked at $294M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on UBS O'Connor's 13F filing for Q3 2021, filed 12 Nov 2021.